InvestorsHub Logo

blue_skies

09/15/19 12:57 PM

#2422 RE: budge #2421

@Budge - What you say for HALO increasing REPR's TAM is true for all pharma reformulating existing drugs for SubQ. The cost advantages and conveniences of home, self administered SubQ infusions is creating a paradigm shift in drug administration. REPR is well positioned to ride this wave!!